Related references
Note: Only part of the references are listed.Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis
Michael Lacy et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Association of serum total cholesterol with pegylated interferon-α treatment in HBeAg-positive chronic hepatitis B patients
Zhen Xun et al.
ANTIVIRAL THERAPY (2019)
Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein
Yaqi Wang et al.
JOURNAL OF LIPID RESEARCH (2018)
Dysregulation of the CD4+ T cells lineage differentiation in dyslipidemic patients and impact of lipoprotein-apheresis treatment: A case study
J. Papin et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon
Marc G. Ghany
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis
Anna S. F. Lok et al.
HEPATOLOGY (2016)
Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
Yi-Xian Shi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer et al.
LANCET (2015)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells
Ying-Ju Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Bile acids increase hepatitis B virus gene expression and inhibit interferon-α activity
Hye Young Kim et al.
FEBS JOURNAL (2010)
Associations Between Serum Lipids and Hepatitis C Antiviral Treatment Efficacy
Darmendra Ramcharran et al.
HEPATOLOGY (2010)
Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells
Stephanie Pollock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hepatitis B virus infection is dependent on cholesterol in the viral envelope
Corinna M. Bremer et al.
CELLULAR MICROBIOLOGY (2009)
Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRα
KyeongJin Kim et al.
BIOCHEMICAL JOURNAL (2008)
Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver
Fu Yang et al.
JOURNAL OF HEPATOLOGY (2008)
Duck Hepatitis B Virus Requires Cholesterol for Endosomal Escape during Virus Entry
Anneke Funk et al.
JOURNAL OF VIROLOGY (2008)
Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?
C-M Chu et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
The hepatitis B virus x protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III
SK Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants
ML Funk et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Share Paper
